Pulmonary hypertension and right-sided heart failure in hemodialysis patients

Lana Adel  Haji; Kais Hasan  Al-Taee; Safa  Almukhtar; Abdulazeez Mohsin  Abdulazeez

doi:10.56056/amj.2023.201

Authors

Lana Adel Haji M.B.Ch.B., a trainee at KHCMS-Nephrology-Duhok Kidney center
Kais Hasan Al-Taee MBChB, FICMS Medicine /FICMS nephrology/FRCP- Duhok Kidney center
Safa Almukhtar MBChB, FICMS Medicine /FICMS nephrology/FRCP- Hawler Kidney center
Abdulazeez Mohsin Abdulazeez MBChB, FIBMS, FRCP, PFIC - Duhok heart center

DOI:

https://doi.org/10.56056/amj.2023.201

Keywords:

End-stage renal disease, Hemodialysis, Pulmonary hypertension, Right-sided heart failure

Abstract

Background & Objectives: Cardiovascular complications are associated with poor outcomes in patients with End stage renal disease. This study is aimed to evaluate the prevalence of pulmonary hypertension and right side heart failure in hemodialysis patients, trying to decrease these complications by referring them to the cardiologist in order to manage them either by medical or interventional methods.

Methods: A cross-sectional study for evaluation the prevalence of pulmonary hypertension and right sided heart failure in hemodialysis patients was carried out in Duhok kidney center in Kurdistan region-Iraq through a duration period of one year from first of February, 2020 to 31^st of January, 2021 for 101 patients. Data were collected which included Age, gender, BMI, causes of renal failure and vascular access, and echocardiography was conducted by a cardiologist, he evaluated them by using tricuspid regurgitation jet peak gradient for pulmonary hypertension, and by using tricuspid annulus plane systolic excursion method for evaluation of right ventricular function.

Results: In the current study 51 females with melasma. Their ages ranged between (19-46) years, with (59.9%) between (28-38) years. The duration of melasma was from 6 months to 9 years. Thirty-eight of them were married and had pregnancy. Thyroid stimulating hormone levels were high in 22 of them (43.1%), 20 out of 22 cases that was had high levels of thyroid stimulating hormone had dermal type of melasma by Wood’s lamp examination and their p-value was significant (0.001).

Conclusion: The prevalence of pulmonary hypertension among patients on hemodialysis in Kurdistan region-Iraq is within the Iraqi and international range studies with low prevalence of right ventricular dysfunction.

Downloads

Download data is not yet available.

References

Mukhtar KN., Mohkumuddin S, Mahmood SN. Frequency of pulmonary hypertension in hemodialysis patients. Pak J Med Sci. 2014; 30(6): 1319–22.

Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25S): D34-41.

Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012; 31(4):373-80.

Taichman DB, Mandel J. Epidemiology of pulmonary arterial hypertension. Clin Chest Med. 2013; 34(4):619-37.

Sikachi RR, Sahni S, Mehta D, et al. Nationwide trends in inpatient admissions of pulmonary hypertension in the United States from 2000 to 2013. Adv Respir Med. 2017; 85(2):77-86.

Naranjo M, Lo KB, Mezue K, et al. Effects of Pulmonary Hypertension and Right Ventricular Function in Short and Long-Term Kidney Function. Curr Cardiol Rev. 2019; 15(1):3-11.

Navaneethan SD, Roy J, Tao K, et al. Prevalence, predictors, and outcomes of pulmonary hypertension in CKD.J Am Soc Nephrol. 2016; 1;27(3):877-86.

Pabst S, Hammerstingl C, Hundt F, et al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study. PLoS One. 2012; 7(4): e35310.

Bolignano D, Rastelli S, Agarwal R, et al. Pulmonary hypertension in CKD. Am J Kidney Dis. 2013; 61(4):612-22.

Westphal JG, Bekfani T, Schulze PC. What's new in heart failure therapy 2018? Interact Cardiovasc Thorac Surg. 2018; 27(6):921-30.

Aoki J, Ikari Y. Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis. Ann Vasc Dis. 2017; 10(4):327-37.

Nootens M, Kaufmann E, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol. 1995;26(7):1581-5.

Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110(10):1308-12.

Manuti JK. Pulmonary Hypertension in Patients with Chronic Renal Failure. Iraqi J Med Sci. 2009; 7(2):104-8.

Emara MM, Habeb MA, Alnahal AA, et al. Prevalence of pulmonary hypertension in patients with chronic kidney disease on and without dialysis. Egypt J chest Dis Tuberc. 2013; 62(4): 761-8.

Hayati F, Mousavi S, Movahed S, Busherhi M. Pulmonary hypertension among patients undergoing hemodialysis. J Renal Inj Prev. 2016; 6(2):122-6.

Zhang Y, Ding X, Rao R, et al. The Prevalence of Pulmonary Hypertension Among Maintenance Dialysis Patients with ESRD and Its Associated Factors: A Retrospective Study. Front Med 2020; 7:570874.

Etemadi J, Zolfaghari H, Firoozi R, et al. Unexplained pulmonary hypertension in peritoneal dialysis and hemodialysis patients. Rev Port Pneumol 2011; 18 (1): 10–4.

Fabbian F, Cantelli S, Molino C, et al. Pulmonary hypertension in dialysis patients: a cross-sectional Italian study. Int J Nephrol 2011; 2011: 283475.

Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 2008; 28 (6): 990–7.

Allawi AA, Alsodani MH, Alqaisi AM. Prevalence and Risk of Pulmonary Hypertension in Chronic Kidney Disease. IJSR. 2015; 6 (7): 947-50.

Yigla M, Fruchter O, Aharonson D. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 2009; 75 (9): 969–75.

Mahdavi-Mazdeh M, Alijavad-Mousavi S, Yahyazadeh H. Pulmonary hypertension in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008; 19 (2): 189–93.

Issa N, Krowka MJ, Griffin MD. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 2008; 86 (10): 1384–8.

Ramasubbu K, Deswal A, Herdejurgen C. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med 2010; 3: 279–86.

Lee C, Liu D, Ding R. Effects of maintenance hemodialysis on right ventricular dysfunction in patients with end-stage renal disease. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014; 45(5):814-8.

Paneni F, Gregori M, Ciavarella G, et al. Right ventricular dysfunction in patients with end-stage renal disease. Am J Nephrol. 2010; 32(5):432-8.

Reque J, Garcia-Prieto A, Linares T, et al. Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients. Am J Nephrol. 2017; 45(2):107-14.

Zhao LJ, Huang SM, Liang T, et al. Pulmonary hypertension and right ventricular dysfunction in hemodialysis patients. Eur Rev Med Pharmacol Sci. 2014; 18(21):3267-73.

Paoletti E, Zoccali C. A look at the upper heart chamber: the left atrium in chronic kidney disease. Nephrol Dial Transplantation. 2014; 29(10): 1847–53.

Querejeta Roca G, Campbell P, Claggett B, et al. Right Atrial Function in Pulmonary Arterial Hypertension. Cardiovasc Imaging. 2015; 8(11): e003521.

Al-Taii MS, Al-Muhanna MY, Al-Ameri AM. The Association between right ventricular dysfunction and pulmonary hypertension in hemodialysis patients with end-stage renal failure in Karbala city. Kerbala Journal of Pharmaceutical Sciences. 2020; 17(17): 79-85.